A feasibility study prior to an international multicentre paediatric study to assess pharmacokinetic/pharmacodynamic sampling and sample preparation procedures, logistics and bioanalysis

被引:5
作者
Ciplea, Agnes Maria [1 ]
Laeer, Stephanie [1 ]
Burckhardt, Bjoern Bengt [1 ]
机构
[1] Heinrich Heine Univ, Inst Clin Pharm & Pharmacotherapy, Bldg 26-22-02-24, D-40225 Dusseldorf, Germany
关键词
Clinical trial; Pilot; Training concept; Pharmacokinetic; Pharmacodynamic; Feasibility;
D O I
10.1016/j.conctc.2018.08.008
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Variability in pre-analytical procedures such as blood sampling, sample preparation and transport can substantially influence bioanalytical results and subsequently impair reliability of data gathered during clinical trials. Especially in vulnerable populations, all efforts should be made to facilitate high-quality data extraction excluding unnecessary or repeated intervention. Methods: The EU-funded LENA project (Labeling of Enalapril from Neonates up to Adolescents) included a feasibility study in its preparatory procedures prior to first-in-child studies. Derived from a regular study visit, it encompassed all procedures, from sampling of two study-specific drugs and four sensitive humoral parameters to bioanalysis, to evaluate the quality of obtained samples and applicability of logistical and bioanalytical procedures. Drug administration to healthy adults was circumvented by pre-spiking the blood collection tubes with a drug solution. Five clinical sites were evaluated. Results: Clinical teams' preparedness and applicability of required sampling procedures was investigated in 18 volunteers, on-site. 97% of collected pharmacokinetic (PK) samples and 93% of samples for humoral parameters were obtained eligibly. Results met expectations, though one team had to be re-trained and performed a re-run. Planned procedures for sampling, sample preparation, transport and analysis were found to be suitable for being applied within paediatric trials. Conclusion: The concept of the presented feasibility study that simultaneously assesses PK/PD sampling, sample preparation, logistics and bioanalysis proved to be a promising tool for trial preparation. It revealed improperly installed processes and bottlenecks that required adjustments prior to start of recruitment. It facilitated high-quality conduct from the first moment of paediatric pivotal studies.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 26 条
[2]   Delay in Specimen Processing-Major Source of Preanalytical Variation in Serum Electrolytes [J].
Baruah, Ankur ;
Goyal, Parul ;
Sinha, Saket ;
Ramesh, K. L. ;
Datta, Rashmirasi .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (12) :CC1-CC3
[3]   Sample Preparation and Extraction in Small Sample Volumes Suitable for Pediatric Clinical Studies: Challenges, Advances, and Experiences of a Bioanalytical HPLC-MS/MS Method Validation Using Enalapril and Enalaprilat [J].
Burckhardt, Bjoern B. ;
Laeer, Stephanie .
INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY, 2015, 2015
[4]   Stability of therapeutic drugs in serum collected in vacutainer serum separator tubes containing a new gel (SST II) [J].
Bush, V ;
Blennerhasset, J ;
Wells, A ;
Dasgupta, A .
THERAPEUTIC DRUG MONITORING, 2001, 23 (03) :259-262
[5]   Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement [J].
Campbell, Duncan J. ;
Nussberger, Juerg ;
Stowasser, Michael ;
Danser, A. H. Jan ;
Morganti, Alberto ;
Frandsen, Erik ;
Menard, Joel .
CLINICAL CHEMISTRY, 2009, 55 (05) :867-877
[6]   Stabilizing drug molecules in biological samples [J].
Chen, Jiwen ;
Hsieh, Yunsheng .
THERAPEUTIC DRUG MONITORING, 2005, 27 (05) :617-624
[7]  
ClinicalTrials.gov, OR MIN EN YOUNG CHIL
[8]  
ClinicalTrials.gov, FOLL UP SAF TRIAL CH
[9]  
ClinicalTrials.gov, OR MIN EN CHILDR HEA
[10]   Developing and evaluating complex interventions: the new Medical Research Council guidance [J].
Craig, Peter ;
Dieppe, Paul ;
Macintyre, Sally ;
Michie, Susan ;
Nazareth, Irwin ;
Petticrew, Mark .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7676) :979-983